Event Brief
FDA approves first gene therapy for hearing loss
Filed: Apr 23, 2026 at 6:00 PM ET
Summary: The FDA approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss.
WHO: Food and Drug Administration
WHAT: approved Regeneron’s Otarmeni
WHEN: Apr 23, 2026 at 4:47 PM ET
WHERE: USA
WHY: Part of a scheduled process.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
🔍 4 sources analyzed
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →